1. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype
- Author
-
Hiwase, Devendra K., primary, Hahn, Christopher N, additional, Tran, Elizabeth Ngoc Hoa, additional, Chhetri, Rakchha, additional, Baranwal, Anmol, additional, Al-Kali, Aref, additional, Sharplin, Kirsty M, additional, Ladon, Dariusz, additional, Hollins, Rachel, additional, Greipp, Patricia T., additional, Kutyna, Monika M., additional, Alkhateeb, Hassan B, additional, Badar, Talha, additional, Wang, Paul Po-Shen, additional, Ross, David M, additional, Singhal, Deepak, additional, Shanmuganathan, Naranie, additional, Bardy, Peter G, additional, Beligaswatte, Ashanka, additional, Yeung, David T, additional, Litzow, Mark R, additional, Mangaonkar, Abhishek A., additional, Giri, Pratyush, additional, Lee, Cindy H, additional, Yong, Angelina, additional, Horvath, Noemi, additional, Singhal, Nimit, additional, Gowda, Raghu, additional, Hogan, William J, additional, Gangat, Naseema, additional, Patnaik, Mrinal M., additional, Begna, Kebede, additional, Tiong, Ing Soo, additional, Wei, Andrew H, additional, Kumar, Sharad, additional, Brown, Anna L, additional, Scott, Hamish S, additional, Thomas, Daniel, additional, Kok, Chung Hoow, additional, Tefferi, Ayalew, additional, and Shah, Mithun Vinod, additional
- Published
- 2022
- Full Text
- View/download PDF